Mark Forsberg
Hematology & Oncology
Credentials: · · ·
History
- 2019–2022
- 2015–2019
Doctor of Medicine
Research
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Blood Cancer Journal · 2024 · 95 citations
AML treatment: conventional chemotherapy and emerging novel agents
Review · Trends in Pharmacological Sciences · 2024 · First of 2 authors · 89 citations
Tasimelteon: a selective and unique receptor binding profile
Neuropharmacology · 2015 · 37 citations
4 papers
3 papers
3 papers
- AP
2 papers
2 papers
2 papers
2 papers
2 papers
